Recent Data on IO-Based Combination Regimens for First-line Treatment of Advanced Endometrial Carcinoma
Krishnansu Tewari, MD, reviews emerging data from two studies investigating immunotherapy-based combination regimens for the first-line treatment of advanced endometrial cancer.
EP: 1.Overview of Endometrial Carcinoma
EP: 2.Patient Profile Presentation: A 64-Year-Old Woman With Recurrent Endometrial Cancer
Now Viewing
EP: 3.Recent Data on IO-Based Combination Regimens for First-line Treatment of Advanced Endometrial Carcinoma
EP: 4.Available Frontline Treatment Options for Patients With Advanced or Recurrent Endometrial Cancer
EP: 5.Approaches to Treatment Sequencing for Patients With Advanced Endometrial Cancer
EP: 6.Patient Profile Presentation: A 68-Year-Old Woman With Recurrent Endometrial Cancer
EP: 7.Emerging Targeted Treatment Options for Patients With Advanced Endometrial Cancer
EP: 8.The Future of Clinical Care for Patients With Advanced Endometrial Cancer
Related Videos
Related Content
